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Regulator of G protein signaling 2 (RGS2) controls G protein coupled receptor (GPCR)
signaling by acting as a GTPase-activating protein for heterotrimeric G proteins. Certain
Rgs2 gene mutations have been linked to human hypertension. Renal RGS2 deficiency is
sufficient to cause hypertension in mice; however, the pathological mechanisms are
unknown. Here we determined how the loss of RGS2 affects renal function. We examined
renal hemodynamics and tubular function by monitoring renal blood flow (RBF), glomeru-
lar filtration rate (GFR), epithelial sodium channel (ENaC) expression and localization, and
pressure natriuresis in wild type (WT) and RGS2 null (RGS2-/-) mice. Pressure natriuresis
was determined by stepwise increases in renal perfusion pressure (RPP) and blood flow,
or by systemic blockade of nitric oxide synthase with L-NG-Nitroarginine methyl ester (L-
NAME). Baseline GFR was markedly decreased in RGS2-/- mice compared to WT con-
trols (5.0 ± 0.8 vs. 2.5 ± 0.1 μl/min/g body weight, p<0.01). RBF was reduced (35.4 ± 3.6
vs. 29.1 ± 2.1 μl/min/g body weight, p=0.08) while renal vascular resistance (RVR; 2.1 ±
0.2 vs. 3.0 ± 0.2 mmHg/μl/min/g body weight, p<0.01) was elevated in RGS2-/- compared
to WT mice. RGS2 deficiency caused decreased sensitivity and magnitude of changes in
RVR and RBF after a step increase in RPP. The acute pressure–natriuresis curve was
shifted rightward in RGS2-/- relative to WT mice. Sodium excretion rate following
increased RPP by L-NAME was markedly decreased in RGS2-/- mice and accompanied
by increased translocation of ENaC to the luminal wall. We conclude that RGS2 deficiency
impairs renal function and autoregulation by increasing renal vascular resistance and
reducing renal blood flow. These changes impair renal sodium handling by favoring
sodium retention. The findings provide a new line of evidence for renal dysfunction as a
primary cause of hypertension.
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Introduction
Essential hypertension is marked by functional changes in primary determinants that control
arterial blood pressure, including augmented total peripheral vascular resistance and/or
increased cardiac output[1, 2]. Increased peripheral resistance can result from defects in the
production of and/or response to endothelium-derived vasodilator factors that counteract
vasoconstriction by norepinephrine release from the sympathetic nervous system or vasocon-
strictor substances including angiotensin II and vasopressin. Increased cardiac output can be
caused by defects in water and electrolyte homeostasis in the kidney parenchyma, thereby lead-
ing to sodium and water retention and blood volume expansion. Thus the kidney plays a major
role in long-term blood pressure control[3, 4].
Unlike many organs where blood flow can be regulated over a wide range to meet changes
in metabolic demand, the kidney is unique in that blood flow is maintained within a narrow
range to sustain glomerular filtration rate (GFR) and water and electrolyte reabsorption.
Despite changes in systemic blood pressure, renal blood flow (RBF) is kept constant due to
autoregulation at pre-glomerular afferent arterioles, which are the major site of renal vascular
resistance regulation[5, 6], and to a lesser degree by autoregulation at post-glomerular efferent
arterioles[7]. Myogenic constriction and tubuloglomerular feedback mechanisms mediate
renal autoregulation; however, intrinsic factors including nitric oxide and agonists for guanine
nucleotide-binding protein (G protein)-coupled receptors (GPCRs), particularly angiotensin II
via the renin-angiotensin system, regulate RBF by modulating renal vascular resistance (RVR)
in pre- and post-glomerular arterioles[8, 9]. Constant RBF ensures that GFR also remains
unchanged within the renal autoregulation range, which is key to maintaining water and elec-
trolyte homeostasis by the renal tubular system. Therefore, defects in renal hemodynamics that
impair RBF and thus GFR potentially impact long-term blood pressure homeostasis by causing
changes in water and electrolyte excretion and reabsorption. Water and electrolyte homeostasis
is mediated by kidney-intrinsic mechanisms, which can be modulated by extrinsic factors,
including the nervous, endocrine, and paracrine systems[10–12] via the activation and regula-
tion of GPCR signaling.
Signaling by G proteins plays several important roles in blood pressure control. Many ago-
nists that affect blood pressure activate receptors that signal via one or more members of the het-
erotrimeric G protein family (Gi/o, Gq/11, Gs, and G12/13)[13, 14]. Aberrant G protein signaling
contributes to the development and establishment of hypertensive disorders[14–16]. Accord-
ingly, GPCRs and the signaling pathways they control remain predominant therapeutic targets
of anti-hypertensive medications, including ANG II and beta-adrenergic receptor blockers.
GPCR signaling is controlled by a family of regulator of G protein signaling (RGS) proteins,
which act as GTPase-activating proteins (GAPs) for G protein alpha subunits by accelerating
the hydrolysis of GTP[17, 18]. By acting as GAPs, RGS proteins regulate the kinetics and
amplitude of G protein signaling[19]. Among ~30 known mammalian RGS proteins[20],
RGS2 is the most potent GAP towards Gq/11-class G proteins[21, 22]. RGS2 deficiency causes
hypertension in mice[15], and certain human hypertension populations harbor mutations that
include Rgs2 single nucleotide polymorphisms predicted to reduce expression or function[23–
26]. RGS2 deficiency in mice is known to augment GPCR-induced vasoconstriction and impair
endothelium-dependent vasodilation[27, 28], which are hallmarks of essential hypertension.
RGS2 deficit has been shown to attenuate vasopressin-mediated regulation of water excretion
[29]. Using kidney cross-transplantation, Gurley and colleagues previously showed that RGS2
deficiency in the kidney is sufficient to cause hypertension[30]. Transplantation of kidneys
from RGS2-/- into wild type mice caused elevated ambulatory blood pressure. Conversely,
hypertension in RGS2-/- mice was abolished following receipt of kidneys from wild type
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donors. While these findings clearly demonstrated the indispensable role for RGS2 in the kid-
ney, how renal function is regulated by RGS2 remains unknown.
Accordingly, here we have assessed whether RGS2 deficiency affects GFR, RBF, and pres-
sure natriuresis, which are crucial for blood pressure control by the kidney. Our study is the
first to identify effects of RGS2 deficiency on renal function. Our results indicate that loss of
RGS2 reduces RBF, GFR and sodium excretion. These findings suggest that hypertension
resulting from downregulation or loss of RGS2 in humans may be attributable in part to aber-
rant renal vascular and tubular function.
Methods
Animals
Studies were performed in accordance with protocols approved by the Animal Studies Com-
mittees of Drexel University College of Medicine andWashington University School of Medi-
cine. All experiments were performed at both institutions using 3–4 month-old male mice that
have been backcrossed more than ten generations into the C57BL/6 background (Charles
River). Generation of RGS2-/- mice has been described previously[31]. Mice were provided
access to food and water ad libitum in our institution’s animal facility at 22°C and a 12-h light/
dark cycle.
Baseline glomerular filtration rate determination
To assess baseline renal function, we determined GFR in anesthetized mice. We used a modi-
fied procedure for measuring GFR in conscious mice based on plasma clearance of fluorescein
isothiocyanate-inulin (FITC-inulin) following a bolus intravenous injection[32]. In this proce-
dure, 5% FITC-inulin (Sigma-Aldrich, St. Louis, MO) was dissolved in 0.9% isotonic saline fil-
tered with a 0.22 μm filter. Under 1.5% isoflurane anesthesia, each animal received a bolus
injection of 3.74 μl/g body weight of 5% FITC-inulin solution via a venous catheter implanted
in the right jugular vein. After FITC-inulin injection, arterial blood was sampled via a carotid
catheter at 3, 7, 10, 15, 35, 55, and 75 min. At each blood sampling point, drawn blood (30 μl)
was replaced with the same volume of heparinized saline. At the end of the experiment, the left
kidney weight was determined following euthanasia by cervical dislocation under deep anes-
thesia. Blood samples were centrifuged for 5 min at 5000 rpm after which 10 μl of plasma was
diluted with 40 μl of HEPES buffer (pH 7.4). FITC-inulin in each sample in a 96-well plate was
measured with 485 nm excitation and 538 nm emission using Synergy HT multi-mode micro-
plate reader (Biotek, Winooski, VT). GFR was calculated using a two-compartment clearance
model as previously described[33].
Glomerular number and surface area determination
Following GFR measurement by plasma clearance of FITC-inulin, the left kidney was accessed
through a flank incision. The renal artery and vein were tied and the kidney excised. After dec-
apsulation, the kidney was cut into small pieces and macerated in 30 ml of 50% (vol/vol) HCl
solution in water at 37°C and continuously stirred for 90 min, as previously described[34].
After replacing the HCl solution with the same volume of distilled water, 1 ml of the kidney
suspension was placed into each chamber of a four-chamber microscope slide. The number of
glomeruli in each chamber was counted using a microscope with 10x magnification. The num-
ber of glomeruli per kidney was determined by taking the average of four counts per slide and
multiplying by the total volume of the kidney suspension. To determine glomerular surface
area, kidney sections and histological staining were performed following a previously described
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protocol[35]. Briefly, paraffin-embedded kidneys were cut into two equal halves in sagittal ori-
entation, and four sections (two sections from each half, 5-μm thick) from each half were
stained with eosin and hematoxylin. A Zeiss Axio Imager M2 equipped with Neurolucida
image acquisition and analysis software was used to trace every superficial and cortico-medull-
lary glomerulus on each kidney section. Glomerular size was estimated from the measurement
of surface area. Cross sectional area of glomeruli from sections at the same level of each geno-
type was measured. To control for differences in size of glomeruli from the cortical surface to
the edge of the renal medulla, two groups of glomeruli in each section were compared: those
close to the edge of the cortex and those close to the cortico-medullary line.
Kidney fibrosis staining and quantification
Kidneys were fixed in formalin followed by tissue processing, mounting, and sectioning. To
determine the presence of perivascular fibrosis, sections were stained in Sirius Red (EMS, Hat-
field PA). Briefly, after paraffin removal and re-hydration, sections were stained in equal parts
Weigert’s Iron Hematoxylin A and B (EMS, Hatfield PA) for 10 min at room temperature. Sec-
tions were then washed twice in distilled water for 3 min per wash. Sirius red was added for 1 h
at room temperature. Slides were washed twice in 0.01N HCl for 3 min per wash. Sections were
then dehydrated and penetrated using ethanol and xylene, respectively. Images were visualized
on an Olympus IX81 inverted microscope using a Photometrics CoolSNAP HQ CCD camera
and were acquired with SPOT 4.7 Basic software. Analysis was conducted using NIH ImageJ
1.49g software. To calculate perivascular fibrosis, the value of fibrosis area was subtracted from
vessel area and divided by the true area of the vessel. True area was calculated by vessel outer
perimeter2 divided by 4π. The value generated was the area of the vessel in true circular form.
In total, 4 randomly selected samples per group were used for analysis. 3 representative renal
vascular images were analyzed per sample.
Extracellular fluid volume expansion and pharmacological challenge
Under isoflurane anesthesia, wild type and RGS2-/- mice were instrumented simultaneously
with a renal flow probe (0.5PSB Nanoprobe with handle, Transonic) for RBF measurement, a
fluid filled carotid artery catheter for blood pressure recording, a jugular vein catheter for fluid
and drug infusion, and a bladder catheter for urine collection. Immediately after the surgical
procedure was completed, the mice were given a bolus injection of isotonic saline (8 μl/g body
weight) containing 2% bovine serum albumin and 0.33% FITC-inulin followed by continuous
infusion of the same solution at 0.5 μl/min/g body weight. After 30 min of equilibration, base-
line urine was collected for another 30 min, and blood sample was collected (50 μl) for the mea-
surement of hematocrit, GFR and plasma electrolyte concentration. This was followed by acute
administration of L-NAME (30 mg/kg, i.v.).
Pressure natriuresis studies
Previously described methods for assessing pressure natriuresis in rodents developed by
Roman, Cowley and others[36–38] were followed with minor modifications. Briefly, wild type
and RGS2-/- mice were uninephrectomized at least two weeks before the experiment.
The right kidney was exteriorized and retracted via the retroperitoneal cavity, following a
right flank incision under isoflurane anesthesia. Two pieces of 6–0 silk were tied around the
right renal vascular pedicle and the ureter, after which the kidney was excised. The right adre-
nal gland was also removed after tying off all major blood vessels to the organ. The incision
was closed by first suturing the muscle followed by closing of the skin incision with surgical sta-
ples and tissue glue.
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On the day of the experiment, uninephrectomized mice were anesthetized with isoflurane
and surgically instrumented with a fluid-filled carotid artery catheter for blood pressure mea-
surement, a PE-10 jugular vein catheter for fluid and drug delivery, and a bladder catheter for
urine collection. 6–0 silk ligatures were placed loosely around the celiac and the superior
mesenteric arteries. The abdominal aorta below the left kidney was isolated from the vena cava
and surrounding connective tissue to allow for stepwise increases in renal perfusion pressure
by abdominal aortic occlusion. The left adrenal gland was then removed, and the kidney dener-
vated by rubbing 10% phenol in 100% ethanol around the renal artery at the point of entry into
the kidney. Shortly after surgical procedures were completed, mice were given a bolus injection
of phosphate-buffered saline (PBS; 8 μl/g body weight) cocktail containing 2% bovine serum
albumin, 1 μg/ml norepinephrine, 0.5 ng/ml arginine vasopressin, 0.2 mg/ml hydrocortisone,
and 0.2 μg/ml aldosterone, followed by continuous infusion of the same solution at 0.5 μl/min/
g body weight according to a previously described protocol[37]. Following a 45 min equilibra-
tion period, renal function was examined over three consecutive 20 min clearance periods: In
period 1, baseline parameters and urine were collected; in period 2, arterial blood pressure and
renal perfusion pressure were elevated by occluding the celiac and the superior mesenteric
arteries with 6–0 silk ligatures; in period 3, renal perfusion pressure was further elevated by
occluding the abdominal aorta below the left kidney with a metal clamp. At the midpoint of
each clearance period, an arterial blood sample (100 μl) was drawn for determination of elec-
trolyte concentration. Heparinized donor blood (100 μl) from RGS2+/- littermates was then
injected to replace the lost volume after each blood draw. Kidney weight was determined at the
end of the experiment. Plasma and urine electrolyte analyses were performed by Washington
University School of Medicine’s Core Laboratory for Clinical Studies. Hemodynamic data were
recorded and analyzed with PowerLab system (ADInstruments).
Tissue preparation for immunohistochemistry
At the end of each volume expansion experiment, the mice were deeply anesthetized with keta-
mine/xylazine (ketamine; 43 mg/kg, i.p., and xylazine; 6 mg/kg, i.p.) and perfused through the
left ventricle with 4% sucrose in 4% paraformaldehyde-phosphate buffered saline solution. The
fixed kidneys were immersed in 100 mMTris-HCl solution for 30 min and transferred into
30% sucrose in PBS overnight. After embedding in TissueTek OCT compound in a Cryomold
vinyl mold, 30 μm-thick sections were cut and immediately used for immunofluorescence
labeling. To this end, kidney sections were incubated in 0.01% Triton X-100 in TBS for 10 min
followed by 1 hr incubation in 1% non-fat milk in TBS-Tween and overnight incubation with
αENaC (1:500, Santa Cruz) or NHE-3 (1:500, Santa Cruz) primary antibody at 4°C. Following
several washes, the tissue was incubated with Alexa Fluor (anti-rabbit IgG, Alexa Fluor 488 or
568 conjugate) secondary antibody for 1 h at room temperature, then washed several times and
mounted on slides. Images were obtained using Olympus IX81 laser scanning confocal micro-
scope. All images were acquired using a 60x oil immersion objective (NA = 1.42) at a pixel size
of 103 nm. To quantify αENaC translocation and clustering, we analyzed αENaC puncta sizes
in raw images acquired by a confocal microscope as previously described[39]. We determined
the sizes of ENaC punctae by measuring the half-maximum of full width using pixel intensity
peaks as a function of distance. On an average, 10 individual puncta were measured from every
image. We then generated puncta size frequency distribution plots to determine the distribu-
tion of ENaC clusters along the lumen of renal tubules in each genotype. Frequency distribu-
tions were fitted to multiple Gaussian functions to determine the size of the most predominant
ENaC clusters in each genotype.
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Renal autoregulation
Mice were instrumented with carotid artery and jugular vein catheters as described above,
except that uninephrectomy was not performed. For acute renal blood flow (RBF) measure-
ments, a renal flow probe (0.5PSB Nanoprobe with handle, Transonic) was placed around the
left renal artery following a left flank incision. 6–0 silk ligatures were placed loosely around the
celiac and the superior mesenteric arteries. At the end of the surgery, the mice were given a
bolus injection of 2% BSA/saline (8 μl/g body weight), followed by a continuous infusion of the
same solution at 0.5 μl/min/g body weight while blood pressure and RBF were recorded contin-
uously at 1000 Hz. After 30 min of equilibration, renal perfusion was increased by tightening
the ligature around the celiac and mesenteric arteries while blood pressure and RBF were con-
tinuously recorded for 20 min.
Data analysis
Hemodynamic data were processed and analyzed as previously described[40, 41]. The recorded
blood pressure and RBF data were analyzed offline using SigmaPlot 12.5 software. The
1000-Hz blood pressure and RBF data were resampled and smoothed by a running average
over 100 point segments. RVR was calculated as mean arterial pressure (MAP) divided by RBF
and normalized to body weight. Renal conductance was calculated as RBF divided by MAP and
normalized to body weight.
The speed of the myogenic response was assessed by determining the slope of a trendline
drawn for the first 10 points of the rapid rising phase of RVR, following a step increase in MAP
by occlusion of the celiac and superior mesenteric arteries. Steady-state autoregulation at 2
minutes following the step increase in MAP was determined by calculating the autoregulatory
index (AI) using the following equation:







Where RBF1 and MAP1 are the average baseline values taken at 10 s before the step increase
in pressure, and RBF2 and MAP2 are the average of values taken from 110 s to 120 s after the
step increase in pressure.
Statistical analysis
All data are mean ± standard error. Baseline GFR was analyzed by one-way analysis of variance
(ANOVA). Unpaired student’s t test was used to compare glomerular number and surface
area. For assessment of within-group effects of increasing perfusion pressure on urine output,
sodium excretion, and renal hemodynamics, one-way ANOVA with repeated measures was
used, and two-way ANOVA with repeated measures was used for between-group comparisons
with Neuman-Keuls post-hoc tests. All other comparisons were performed using student’s t
test or ANOVA where appropriate. A p<0.05 was considered statistically significant.
Results
Decreased baseline GFR in RGS2-/- mice
Gurley and colleagues showed previously that RGS2 deficiency in the kidney plays a causal role
in blood pressure elevation in RGS2-/- mice[30]. To determine how the loss of RGS2 affects
renal function, we analyzed GFR, glomerular number and size, renal hemodynamics, and pres-
sure natriuresis in wild type and RGS2-/- mice. First, we determined baseline GFR in anesthe-
tized mice by measuring plasma clearance of FITC-inulin following a single bolus intravenous
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injection. GFR was markedly decreased in both RGS2-/- and RGS2+/- mice compared to con-
genic wild type controls (Fig 1A). We confirmed that GFR was markedly reduced in RGS2-/-
mice by using urine clearance of inulin with continuous infusion of saline/BSA containing
FITC-inulin. As shown in Fig 1B, this approach verified that RGS2-/- GFR was reduced relative
to wild type mice. We noted that GFR measured by plasma inulin clearance was approximately
two times higher than that measured by urine inulin clearance, as previously reported[42].
This difference could have resulted from the GFR estimation calculation used in the former
method[32]. Nevertheless, both methods showed a similar trend of decreased GFR in RGS2-/-
mice. We next determined whether decreased GFR in RGS2-/- mice might be due to reduction
in nephron number. The average number of nephrons per kidney was determined by counting
the number of isolated glomeruli per kidney after hydrochloric acid maceration. As shown in
Table 1, nephron number was higher in RGS2-/- mice compared to wild type controls
(RGS2-/-; 12270 ± 677 vs. WT; 9209 ± 421, p<0.01). Because wild type and RGS2-/- kidney
weights were similar, we determined whether there was any change in the size of glomeruli that
potentially compensates for differences in glomerular number. As shown in Table 1, the aver-
age surface area of superficial glomeruli was smaller in RGS2-/- relative to wild type controls.
Cortico-medullary glomeruli showed a similar trend, though the difference did not reach statis-
tical significance (p = 0.06). These data indicated that impaired GFR is caused by defective kid-
ney function but not glomerular deficit.
Decreased total RBF and augmented baseline RVR in RGS2-/- mice
Previous in vitro studies have shown that RGS2 modulates stretch- and GPCR-induced vaso-
constriction of renal interlobar arteries[27]. Here, we determined whether reduced GFR
observed in RGS2-/- mice might be due to decreased renal perfusion arising from increased
vasoconstriction. Fig 1C–1E summarize data including baseline mean arterial pressure (MAP),
RBF, and RVR of wild type and RGS2-/- mice under isoflurane anesthesia. Baseline MAP was
~10 mmHg greater while RVR also increased by ~1 mmHg/μl/min/g body weight in RGS2-/-
mice compared to wild type controls. These changes were accompanied by a reduction in base-
line RBF (Fig 1D) while filtration fraction was unchanged (Fig 1F) in RGS2-/- mice. These
results suggested that decreased GFR in RGS2-/- mice is due at least partly to decreased renal
perfusion and increased resistance of the renal vasculature.
Increased renal perivascular fibrosis in RGS2-/- mice
RGS2 deficiency results in increased vasoconstrictor signaling[27] in renal arteries and acceler-
ation of renal fibrosis induced by ureteral obstruction[43]. Because chronic vasoconstriction
can lead to tissue hypoperfusion and ischemic damage, we determined whether decreased RBF
in RGS2-/- resulted in renal injury. As shown in Fig 2A and 2C, RGS2-/- mice developed
remarkable perivascular fibrosis that was absent in wild type controls. When normalized to
total vessel cross-section, RGS2-/- kidneys showed a 11-fold increase in perivascular fibrosis
relative to wild type (Fig 2E). In contrast to other models of renal fibrosis, we did not observe
any significant glomerular or interstitial fibrosis (Fig 2B and 2D). Furthermore, urinary protein
excretion was unaffected in RGS2-/- mice (Fig 2F), suggesting the absence of glomerular filtra-
tion unit damage.
Effect of RGS2 deficiency on whole kidney steady-state autoregulation
To determine how baseline RBF and GFR were decreased in RGS2-/- mice, we assessed steady-
state autoregulation under isoflurane anesthesia. Fig 3 shows MAP-RBF, MAP-RVR and
MAP-conductance relationships before and 2 min after a step increase in renal perfusion
Renal Regulation by RGS2
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Fig 1. Baseline glomerular filtration rate (A, B), mean arterial pressure (MAP; C), renal blood flow
(RBF; D), renal vascular resistance (RVR; E), and filtration fraction (F) of wild type (RGS2+/+), RGS2
heterozygous (RGS2+/-), and RGS2 knockout (RGS2-/-) mice. Values are mean ± SE. *,**P < 0.05, 0.01
vs. RGS2+/+; #P < 0.05 vs. RGS2+/-. BW, body weight.
doi:10.1371/journal.pone.0132594.g001
Table 1. Kidneymorphometry of 3-4-month old wild type (RGS2+/+) and RGS2 knockout (RGS2-/-) mice. Values are mean ± SE.
Genotype RGS2+/+ (n = 7) RGS2-/ (n = 5) P value
Body weight (g) 25 ± 1 29 ± 1 0.047
Kidney weight (g) 0.179 ± 0.01 0.198 ± 0.02 0.326
Number of glomeruli per kidney 9209 ± 421 12270 ± 677 0.002
Superﬁcial glomerular surface area (μm2) 2749 ± 57 2423 ± 104 0.012
Cortico-medullary glomerular surface area (μm2) 5766 ± 442 4801 ± 279 0.060
doi:10.1371/journal.pone.0132594.t001
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pressure. Steady state MAP increased ~30 mmHg above baseline in wild type whereas it
increased ~20 mmHg above baseline in RGS2-/- mice. A similar shift in RBF, RVR and con-
ductance was observed in wild type and RGS2-/- mice (Fig 3A, 3B and 3C). However, the mag-
nitude of change in RVR (WT: 1.6 ± 0.3 vs. RGS2-/-: 1.0 ± 0.1 mmHg/μl/min/g body weight)
and conductance (WT: -0.18 ± 0.04 vs. RGS2-/-: -0.1 ± 0.02 μl/min/mmHg/g body weight) was
greater in wild type relative to RGS2-/- mice. As shown in Fig 3D, autoregulatory index (AI), a
measure of autoregulation efficiency was not different between the groups. In addition, no cor-
relation was found between baseline MAP and AI in both genotypes (data not shown).
Together the results indicate that RGS2 deficiency decreases the responsiveness but not the
steady-state autoregulation of renal conductance.
Fig 2. Structural analysis of renal vasculature in wild type (RGS2+/+) and RGS2 knockout (RGS2-/-)
mice. Sirius red staining for tissue fibrosis in RGS2+/+ (A and B) and RGS2-/- (C and D) kidneys. Arrows
indicate renal microvessels and arrowheads indicate glomeruli. E, Quantification of perivascular fibrosis in
RGS2+/+ and RGS2-/- kidneys. RGS2-/- renal microvessels showed a 11-fold increase in perivascular
fibrosis relative to RGS2+/+ vessels. F, 24-hr proteinuria was similar between RGS2+/+ (n = 7) and RGS2-/-
(n = 5) mice. **P < 0.01 vs. RGS2+/+.
doi:10.1371/journal.pone.0132594.g002
Renal Regulation by RGS2
PLOSONE | DOI:10.1371/journal.pone.0132594 July 20, 2015 9 / 20
RGS2 deficiency decreases the kinetics of RBF, RVR, and renal
conductance response to a step increase in renal perfusion pressure
To determine the mechanism whereby loss of RGS2 results in decreased responsiveness of
renal autoregulation, we assessed the kinetics of RBF, RVR and renal conductance in response
to a step increase in renal perfusion pressure. The time course of changes in MAP, RBF, RVR,
and renal conductance within the first 60 sec of superior mesenteric and celiac artery occlusion
are shown in Fig 4. The initial sharp rise in MAP was similar between the two genotypes (Fig
4A). In both groups, RBF showed a biphasic response with initial increase prior to the subse-
quent decline to steady state levels below baseline within ~20 sec (Fig 4B). RVR rose rapidly
within the first 20 sec following the step increase in MAP, and it continued to rise albeit at a
slower rate until it plateaued at ~40 sec in both groups (Fig 4C). Changes in renal conductance
followed a similar pattern but in the opposite direction as RVR (Fig 4D); however, the slower
phase of decline in conductance in wild type was more apparent than in RGS2-/- mice. The
rapid rise in RVR is similar to previous studies in which this phase of the autoregulatory
response reflects the speed and/or strength of the myogenic response of the renal vascular bed
[40, 41]. To determine the effect of RGS2 deficiency on the speed of myogenic response to
increased renal perfusion pressure, we calculated the speed of the myogenic mechanism as the
slope of a trendline drawn through 10 data points that spanned the first 10 seconds of the rapid
rise phase of the RVR curve. As shown in Fig 4E, the slope of the RGS2-/- rapid phase trended
Fig 3. Effects of increasing renal perfusion pressure (MAP) on renal blood flow (RBF, A), renal
vascular resistance (RVR, B), and renal conductance in wild type (RGS2+/+, n = 7) and RGS2
knockout (RGS2-/-, n = 8) mice. Increased MAP caused a greater change in RVR and conductance of
RGS2+/+ relative to RGS2-/- mice. D, autoregulation index indicating no difference in steady-state
autoregulation efficiency between RGS2+/+ and RGS2-/- mice. Values are mean ± SE. **P < 0.01 vs. RGS2
+/+ baseline RVR and conductance; n.s., not significant vs. RGS2+/+. BW, body weight.
doi:10.1371/journal.pone.0132594.g003
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lower relative to wild type slope (0.04 ± 0.01 vs. 0.05 ± 0.01 mmHg/μl/g body weight/s,
P = 0.07). Because baseline MAP was different between the two groups, we next determined
whether slower myogenic response in RGS2-/- mice was due to higher baseline renal perfusion
pressure. Fig 4F shows that there was no correlation between baseline MAP and RVR slope.
Altogether, these results suggest that RGS2 deficiency alters renal autoregulation by causing a
slight reduction in the speed of the myogenic response.
Fig 4. Time course of renal hemodynamic response to a step increase in perfusion pressure. Fig A-D
show responses of mean arterial pressure (MAP, A), renal blood flow (RBF, B), renal vascular resistance
(RVR, C), and renal conductance (D), 10 seconds before and 60 seconds after occluding celiac and superior
mesenteric arteries of isoflurane-anesthetized mice. E, a trendline drawn through the first 10 seconds after
the beginning of increase in RVR following a step increase in MAP to determine the speed of myogenic
response. Each point is the average from several animals (RGS2+/+; n = 6 and RGS2-/-; n = 7) at the time
points in each group. The average slope of each trendline shown in the linear equations in E is equal to the
mean of slopes from trendlines of all animals (used in panel 3F) in each group. F, scatter plot showing the
correlation between baseline MAP vs. the slope of the rapid phase of RVR response to a step increase in
renal perfusion pressure of wild type (RGS2+/+) and RGS2 knockout (RGS2-/-) mice. Each point location
represents the intersection of the RVR slope and baseline MAP of individual mice in each group. Values are
mean ± SE. BW, body weight.
doi:10.1371/journal.pone.0132594.g004
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RGS2 deficiency causes a rightward shift of renal pressure-natriuresis
relationship
To determine further how renal RGS2 deficiency may lead to increased blood pressure, we
assessed renal pressure-natriuresis relationships. Fig 5 shows the effects of increasing renal per-
fusion pressure on urine flow rate (diuresis) and sodium excretion (natriuresis) in uninephrec-
tomized wild type and RGS2-/- mice under isoflurane anesthesia. Renal perfusion pressure
increased ~20 mmHg in each genotype when the mesenteric and celiac arteries were occluded.
Renal perfusion pressure increased further in both groups following occlusion of the abdomi-
nal aorta below the left kidney, in addition to occlusion of the mesenteric and celiac arteries.
Renal perfusion pressure in wild type mice rose to 97 mmHg while RGS2-/- mice pressure rose
to 110 mmHg. Under this condition, renal perfusion pressure (97 ± 3 mmHg) in wild type
mice was equivalent to that of RGS2-/- mice prior to aortic occlusion (100 ± 2 mmHg). Thus,
these conditions were used to compare the regulation of urine output, natriuresis, and renal
hemodynamics by renal perfusion pressure in wild type and RGS2-/- mice at equivalent blood
pressures. This analysis indicated that pressure-diuresis and pressure-natriuresis curves of
RGS2-/- mice shifted to the right compared to wild type control mice (Fig 5A and 5B) with no
apparent difference in the slope of the two curves (WT: 1.4 ± 0.6 vs. RGS2-/-: 1.4 ± 0.5 nmol/
min/mmHg). At a renal perfusion pressure of ~100 mmHg, urine flow (WT: 0.34 ± 0.03 vs.
RGS2-/-: 0.19 ± 0.02 μl/min/g body weight) and sodium excretion (WT: 57.3 ± 7.2 vs. RGS2-/-:
29.4 ± 4.1 nmol/min/g body weight) rates were reduced in RGS2-/- mice. In contrast, potas-
sium excretion rates were similar between the two genotypes (WT: 27.9 ± 9.3 vs. RGS2-/-:
30.0 ± 12.3 nmol/min/g body weight). Together, these results suggested that in the absence of
RGS2, there is a re-setting of the equilibrium pressure or the set-point at which sodium excre-
tion matches sodium intake.
Urinary sodium excretion following plasma volume expansion is
decreased in RGS2-/- mice
To determine whether the absence of RGS2 alters tubular sodium reabsorption, wild type and
RGS2-/- mice were subjected to acute plasma volume expansion by continuous infusion of iso-
tonic saline. To stimulate the excretion of excess water and sodium, arterial blood pressure was
increased by systemic administration of the non-selective nitric oxide synthase inhibitor,
L-NAME after baseline recordings. As expected, blood pressure, RVR and GFR increased
whereas RBF decreased in both genotypes following L-NAME administration (Fig 6A–6D).
Although sodium and potassium excretion rate increased in both genotypes following
L-NAME injection, the natriuretic response was much more robust and reached significance
only in wild type mice (Fig 6E and 6F), suggesting that sodium reabsorption was increased in
RGS2-/- mice. To test this hypothesis, we determined whether RGS2 deficiency affected the
expression and/or tissue distribution of Na+ channels in renal tubules. Tissue distribution (Fig
7A and 7D) and expression level of the proximal tubule sodium transporter, NHE-3, were
unaffected by the absence of RGS2. In contrast, tubules from RGS2-/- mice showed increased
luminal localization of ENaC, the distal tubule sodium transporter, whereas it was uniformly
distributed in tubules from wild type animals (Fig 7B, 7C, 7E and 7F). Because ENaC can
assemble and/or cluster in different stoichiometries and modular arrangements that can alter
channel activity[44–48], we determined whether the absence of RGS2 affected the apparent
size of luminal ENaC assemblies in renal tubules. As shown in Fig 7G, there was a heteroge-
neous population of luminal ENaC in the tubules of both genotypes. However, the average size
of punctae of the highest frequency, determined from the frequency distribution plot (Fig 7G),
was larger in RGS2-/- relative to those in wild type tubules (Fig 7H), suggesting a higher order
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arrangement or clustering in the absence of RGS2. These results together indicated that loss of
RGS2 causes alterations in cellular distribution or assembly of ENaC that may promote sodium
retention by the renal tubular system.
Discussion
The absence of RGS2 in the kidney plays a causal role in the development of hypertension in
RGS2-/- mice. However, the renal mechanisms that are affected in these mice are poorly under-
stood. In this study, we have shown that RGS2 deficiency impairs renal function by augment-
ing renal vascular resistance, decreasing renal blood flow and glomerular filtration shifting the
pressure-natriuresis relationship to higher pressures, and decreasing renal sodium excretion.
These findings significantly expand understanding of how defects in renal mechanisms of
blood pressure control contribute to hypertension due to the loss of Rgs2, a hypertension sus-
ceptibility gene. While renal dysfunction is a hallmark of essential hypertension, what still
remain unresolved are the primary mechanisms and how they contribute to long-term blood
pressure elevation.
Prior evidence and findings presented herein are consistent with the hypothesis that pri-
mary renal microvascular defects play a causal role in the development of hypertension in the
absence of RGS2. We have found that elevated blood pressure in the absence of RGS2 is accom-
panied by increased RVR and impaired renal blood flow and GFR. These findings agree with
those in previous work showing that 1) RGS2 tightly regulates signaling by Gq/11 class G pro-
teins[21, 22]; 2) several agonists including angiotensin II, endothelin-1, norepinephrine, and
Fig 5. Effect of increasing renal perfusion pressure (MAP) on urine flow rate (A, UV), sodium excretion
rate (UVNa+, B), potassium excretion rate (C), and fractional sodium excretion (D, FENa) in wild type
(RGS2+/+, n = 12) and RGS2 knockout (RGS2-/-, n = 8) mice. Values are mean ± S.E. #P < 0.05 vs.
RGS2+/+ baseline MAP; **P < 0.01 vs. RGS2+/+ UV and UV Na+ at equivalent MAP of ~100 mmHg. BW,
body weight.
doi:10.1371/journal.pone.0132594.g005
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vasopressin that regulate renal function activate GPCRs coupled to Gq/11[49, 50]; 3) signaling
by Gq/11 class G proteins plays key roles in several GPCR agonist-evoked physiological
responses that are key to proper renal function, including vessel tone[51, 52]; and 4) renal
interlobar arteries from RGS2-deficient mice show augmented vasoconstriction triggered by
GPCRs coupled to Gq/11 class G proteins[27]. Consistent with these lines of evidence, we found
that renal blood flow at baseline is markedly decreased in RGS2-/- mice. Moreover, we found
that basal renal vascular resistance is augmented in the absence of RGS2. Whereas renal autore-
gulation was responsive to a step increase in renal perfusion pressure in wild type and RGS2-/-
mice, the sensitivity of the autoregulatory response was decreased in RGS2-/- mice, suggesting
altered renal autoregulation in the absence of RGS2. We noted that the speed of myogenic
mechanism of autoregulation in RGS2-/- mice tended to be slower in response to a step
increase in renal perfusion pressure. This result was unexpected and at variance with the find-
ings by Hercule et al[27]. In their study, interlobar arteries of RGS2-/- mice showed augmented
myogenic response to increasing intraluminal pressure ex vivo, suggesting that pre-glomerular
autoregulation is enhanced in RGS2-/- kidneys to limit the transmission of higher systemic
pressure to the glomerulus. However, because RBF and GFR were attenuated in RGS2-/- mice,
these changes in renal autoregulation may be maladaptive and further exacerbate or help per-
petuate hypertension. In line with this suggestion, RGS2-/- renal microvessels have increased
perivascular fibrosis that may occur as a consequence of renal hypo-perfusion and ischemic
Fig 6. Effects of systemic administration of the non-selective eNOS inhibitor, L-NAME, on renal perfusion pressure (MAP), renal blood flow (RBF),
renal vascular resistance (RVR), glomerular filtration rate (GFR), and sodium (UVNa+) and potassium (UK+V) excretion rate in wild type (RGS2+/+,
n = 4) and RGS2 knockout (RGS2-/-, n = 5) mice. Values are mean ± SE. #, ##P < 0.05, 0.01 vs. corresponding baseline; *,**P < 0.05, 0.01 vs. RGS2+/
+ mice. BW, body weight.
doi:10.1371/journal.pone.0132594.g006
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Fig 7. Analysis of renal tubular expression and distribution of sodium/proton exchanger-3 (NHE-3) and epithelial sodium channel (α-ENaC). A and
D show representative images of expression and distribution of NHE-3 in wild type (RGS2+/+) and RGS2 knockout (RGS2-/-) renal tubules. B and E show
representative images of α-ENaC expression and distribution. C and F are expanded inserts in B and E, respectively, showing a marked increase in luminal
border localization of α-ENaC in RGS2-/- relative to wild type tubules. G, Frequency distribution of α-ENaC punctate size in the luminal border of renal
tubules. H, average size of luminal α-ENaC granules. Values are mean ± SE. *P < 0.05 RGS2+/+ vs. RGS2-/- mice.
doi:10.1371/journal.pone.0132594.g007
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injury[53]. Without altering the magnitude of renal vascular myogenic response in RGS2-/-
mice, renal perivascular fibrosis could also contribute to decreased sensitivity due to increased
stiffness of the extracellular matrix of the vessel wall[54].
As previously reported, augmented vasoconstriction of RGS2-deficient arteries evoked by
GPCR agonists may occur due to prolonged activity or exaggerated Gq/11 signaling in the
absence of RGS2[27]. In light of the additional findings in this study, what remain to be deter-
mined are the mechanisms by which regulation of G protein signaling by RGS2 modulates
renal autoregulation in physiologically critical vessels, particularly pre- and post-glomerular
arterioles. Achieving these goals would require a detailed assessment of the role of RGS2 in
myogenic response and tubuloglomerular feedback, the principal mechanisms that mediate
renal autoregulation.
Does impaired RBF and GFR affect electrolyte and water homeostasis that ultimately impact
long-term blood pressure homeostasis in RGS2 deficiency? We have addressed this question by
assessing the effect of RGS2 deficiency on the status of the pressure-natriuresis relationship.
Our results show that the pressure-natriuresis curve of RGS2-/- mice is shifted rightward rela-
tive to wild type mice with no change in slope, indicating a re-setting of the equilibrium set-
point to higher blood pressure. Although the shift in the acute pressure-natriuresis curve is
similar to that observed in salt-independent hypertension[55], decreased sodium excretion rate
in RGS2-/- mice at a renal perfusion pressure similar to wild type controls suggests that
increased sodium retention contributes to the development of hypertension in the absence of
RGS2. In agreement with this hypothesis, Gurley and colleagues previously showed that hyper-
tension in RGS2 mice could be enhanced by high salt diet[30]. Furthermore, we observed
increased luminal distribution or assembly of α-ENaC in RGS2-/- mice. The physiological rele-
vance of this finding is that the insertion, retrieval or assembly of membrane ENaC subunits
can vary in response to genetic or physiological perturbations. In this regard, kidneys from
Dahl salt-sensitive rats, which transport twice as much sodium as their salt-resistant cohorts
under baseline conditions[56], further increase membrane ENaC expression in response to
high salt diet[47]. Furthermore, increased membrane localization of ENaC is associated with
increased channel open probability and sodium transport in epithelial cells of distal nephrons
[57, 58] and other organs[59, 60]. Thus, increased sodium retention due to increased tubular
sodium reabsorptive capacity mediated by ENaC likely contributes to hypertension in RGS2-/-
mice. Increased ENaC activity and sodium retention could also be facilitated by high order
arrangement or clustering, favoring a particular stoichiometry of the subunits in the plasma
membrane[48, 61]. In line with this suggestion, we found that luminal membrane localization
and clustering of α-ENaC, were increased in RGS2-/- kidneys. However, what cannot be ascer-
tained from the current study is whether alterations in tubular sodium handling in the absence
of RGS2 occur as a consequence of a primary vascular defect causing decreased RBF and GFR,
thereby re-setting the pressure-natriuresis relationship to achieve sodium balance, or whether
higher perfusion pressure with lower GFR may be a consequence of primary perturbations in
renal tubular sodium reabsorption mechanisms whereby increased sodium-retaining effects
could be elicited by inappropriate activation of GPCR signaling in the absence of RGS2.
Our pressure-natriuresis experiments were performed under conditions in which kidney-
extrinsic factors, i.e. neural and circulating hormonal input to the kidney, were clamped. While
this protocol remains the optimal method to assess the role of hypertension candidate gene
products in renal-intrinsic mechanisms as pertains to acute pressure-natriuresis relationship in
mice under anesthesia, the use of continuous infusion of the hormone cocktail containing vaso-
active agents may have obscured the effect of RGS2 deficiency on vascular-intrinsic mecha-
nisms that influence renal function. Nonetheless, it is possible that RGS2 deficiency may have a
direct effect on tubular sodium handling, since raising renal perfusion pressure in the absence
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of any hormone cocktail also led to decreased sodium excretion. We also note that glomerular/
nephron number is ~30% higher in RGS2-/- compared to wild type controls despite a lack of
difference in kidney weight. The overall glomerular surface area appears to be smaller; how-
ever, it remains to be determined whether such a difference between GFR and nephron number
in RGS2-/- mice is part of a developmental adaptation elicited by persistent elevation of
homeostatic blood pressure.
In conclusion, our study shows that RGS2 deficiency impairs renal function by decreasing
glomerular filtration rate and renal blood flow, while augmenting renal vascular resistance and
sodium retention. These findings may have implications in the choice of anti-hypertensive
medication because, in hypertension patients who harbor Rgs2mutations that decrease protein
expression and/or function, therapies that concurrently target vasoconstrictor and tubular
GPCR signaling may be more effective drug of choice than those drugs that only affect one
aspect of renal function.
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